NCT03609814View on ClinicalTrials.gov

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 26, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Hematologic MalignanciesNonmalignant DiseasesImmunodeficienciesHemoglobinopathiesGenetic Inborn Errors of MetabolismFanconi's AnemiaThalassemiaSickle Cell Disease
Interventions
DRUG

Clofarabine

Given IV

DRUG

Fludarabine Injection

Given IV

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT03609814 - Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT) | Biotech Hunter | Biotech Hunter